首页>
外国专利>
The reagent, the methods and kits: molecular diagnostic testing and drug screening for the early detection of colorectal cancer
The reagent, the methods and kits: molecular diagnostic testing and drug screening for the early detection of colorectal cancer
展开▼
机译:试剂,方法和试剂盒:用于大肠癌早期检测的分子诊断测试和药物筛选
展开▼
页面导航
摘要
著录项
相似文献
摘要
A novel approach to the early detection of colorectal cancer ("CRC"), using a molecular diagnostic test to evaluate grossly normal-appearing colonic tissue for the early detection of colorectal cancer is disclosed. Such grossly normal-appearing colonic mucosal cells may be collected from non-invasive or minimally invasive procedures. The use of novel biomarker panels for drug screening also is disclosed. Such biomaker panels may be used wholly or in part as surrogate endpoints for monitoring effectiveness of a prospective drug in the intervention of pathologies, such as cancers, for example CRC, lung, prostate, and breast, and neurodegenerative diseases, for example Alzheimer's and ALS.
展开▼